CanaQuest Bolsters Team for CQ-001 Trials

By Patricia Miller

Jun 12, 2024

CanaQuest Medical (OTC: CANQF) adds experts to advance CQ-001 through clinical trials for FDA approval in epilepsy.

a modern laboratory setting with scientists working on drug discovery.

Drug discovery

Related Articles:

Explore more on these topics:

Pharmaceuticals Life Sciences Tools and Services Healthcare

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.